KDM1A and familial pancreatic carcinoma: Recent studies have found that HOXA-AS2 could directly interact with enhancers of EZH2 and lysine-specific demethylase 1 (LSD1) involved in pancreatic cancer and acute myeloid leukemia [42, 43].